NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has raised $33 million in private financing. To date, the company has raised $166 million.

"We welcome the additional equity capital to further accelerate growth of the core gene synthesis business, as well as pharmaceutical discovery and data storage vertical strategies," Twist CEO Emily Leproust said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.